The present disclosure relates to an oxygen mask comprising a mask body defining a cavity configured to be positioned, over the mouth and nose of a patient, an oxygen port formed on the upper half of the mask body, an annular aperture formed on the mask body, and at least one vent port formed on the mask body, wherein each vent port is formed on the bottom half of the mask body in a manner that patient’s exhaled gases are directed towards the vent port.

A positive pressure ventilation (PPV) appliance module includes an adapter that couples to a port on an NIV mask and an appliance for performing a respiratory care procedure. The adapter is configured to form a PPV seal with the port of the PPV mask and also form a PPV seal with the appliance. The PPV appliance module allows clinicians to perform procedures through the NIV mask without disrupting the therapeutic pressure.

The invention relates to an inhalable gaseous medicament containing argon gas for use in combination with a mechanical thrombectomy for treating, reducing or resorbing brain lesions subsequent to an ischaemic stroke in an individual. Preferably, the proportion by volume of argon is between 30 and 79%. The mechanical thrombectomy can be accompanied by a drug-based thrombolysis to dissolve the clot and to thin the blood of the patient.

Devices, systems, and methods for delivering fluid therapy to a patient are disclosed herein. An exemplary method can comprise obtaining a urine output rate from a patient; causing a diuretic to be provided to the patient at a dosage rate, wherein the dosage rate is increased over a period of time such that the urine output rate increases to be above a predetermined threshold within the period of time; and causing a hydration fluid to be provided to the patient at a hydration rate. The hydration rate can be set based on the urine output rate to drive net fluid loss from the patient.

A device for administration of substances onto an epicardial surface of a heart includes a frame structure for at least partially encircling a circumference of the heart which is able to assume shaping, positioning, guiding and stabilizing functions. The frame structure may be coupled to a heart-shaped sleeve. A substance carrier for accommodating the substances to be administered may be coupled to the device.

Described are systems and methods for administration of nitric oxide (NO) with use of left ventricular assists devices (LVADs), as well as systems and methods for monitoring the NO delivery devices and/or the LVAD.

A ventilation system for ventilation of a patient includes a patient interface device for attaching to the patient and a measuring and analysis device for measuring and analyzing breathing of the patient. The measuring and analysis device includes a connector housing defining a passage. A first portion of the connector housing is connected to the patient interface device. The measuring and analysis device further includes an air flow sensor and a pressure sensor disposed in the connector housing for measuring an air flow rate through the connector housing and a pressure in the connector housing respectively. The present device also includes a processor configured for data acquisition, data storage, data processing, and data output based on the air flow rate and the pressure, whereby the ventilation system is operable with real-time feedback based on the data output. A method for administering cardiopulmonary resuscitation is also provided.

An apparatus may be configured for providing feedback to caregivers during a code blue scenario when adhered to the chest of a subject undergoing resuscitation by sensing and transmitting information associated with the code blue scenario. Such information may include one or more of vital signs of the subject during resuscitation, information associated with chest movements of the subject during resuscitation, and audio information from an environment of the subject during resuscitation. One or more processors may generate real-time feedback for communication to the caregivers during the code blue scenario based on the sensed and transmitted information.

Methods and systems are described for producing non-invasive and targeted neuronal lesions using magnetic resonance and acoustic energy. Imaging data corresponding to a region of interest is obtained, the region of interest within an imaging subject. Information indicative of a target region within the region of interest is received from the obtained imaging data. Focused acoustic energy directed to the target region within the region of interest is generated to disrupt a barrier between a therapeutic agent and parenchymal tissue in response to insonification by the focused acoustic energy, the therapeutic agent comprising a neurotoxin and microbubbles.

Disclosed are systems and processes related to cardiopulmonary resuscitation (CPR). One embodiment of the system comprises an inspiration chamber and an expiration chamber, which work cooperatively to provide gas (e.g., Oxygen (O.sub.2)) to a subject (e.g., human patient) during inspiration and extract and expel expired gas (e.g., Carbon Dioxide (CO.sub.2)) from the subject during expiration as a medical professional applies CPR to the subject. In other words, this disclosure provides systems and processes that allow for substantially synchronous chest compressions with positive pressure active inspirations and, also, substantially synchronous chest decompressions with negative pressure active expirations.